OUR INNOVATIONS & EARLY STAGE STARTUPS
HEART AND CARDIOVASCULAR (9)
BioLeonhardt
Read More
heart regeneration = complete animal studies and launch OUS clinical study > find strategic partner – www.bioleonhardt.com
AortaCell
Read More
aorta regeneration = complete animal studies – https://leonhardtventures.com/aortacell/
BioPace
Read More
biological pacemaker regeneration = complete animal studies – https://leonhardtventures.com/bio-pace/
Valvublator
Read More
heart valve regeneration = finish prototype development and lab studies and launch animal studies – www.valvublator.com
VibroCell
Read More
(includes CoroStim) – vibrational energy to prevent clots, plaque, calcification = finish prototype development and lab studies + complete animal studies – https://leonhardtventures.com/vibrocell/
Second Heart Assist, Inc.
Read More
VascuStim
Read More
(formerly MyoStim Peripheral, includes EndoCell) – limb salvage regeneration, blood flow improvement for critical limb ischemia, diabetic leg and foot ulcer treatment, artery regeneration = complete international registry clinical study with multiple arms > find strategic partner – www.vascustim.com ;
PressureStim
Read More
bioelectric treatment of high blood pressure via improved arterial elasticity and bioelectric membrane potentials management = complete animal studies – http://pressurestim.com/
BRAIN (4)
CerebraCell
Read More
MemoryStim
Read More
SecondBrain
Read More
bioelectric gut microbiota and enteric nervous system treatment
TremorStim
Read More
bioelectric hand tremor treatment
CANCER TREATMENT (1)
CancerCell
Read More
bioelectric cancer tumor treatment + regeneration = complete lab + animal studies and launch first-in-man studies OUS > find strategic partner – www.cancercellinc.com;
MAJOR ORGAN REGENERATION (12)
EyeCell
Read More
eye regeneration = complete small and large animal studies – eye-cell.com
PancreaCell
Read More
pancreas regeneration = complete animal studies – https://leonhardtventures.com/pancreacell/
RegenaLung
Read More
(includes ECMO-Cath) – lung regeneration (includes 50% owned subsidiary RegenaLung COPD) cannula for infusing oxygen directly into the blood using an oxygenator, a medical device that acts as an artificial lung = find research partner + complete animal studies – https://leonhardtventures.com/regenalung/
LiverCell
Read More
liver regeneration = find a research partner (DUKE?) + complete animal studies – Livercellstim.com
KidneyCell
Read More
kidney regeneration = find a research partner + complete animal studies – www.kidney-cell.com ;
EarCell
Read More
ear hearing regeneration = find a research partner + complete animal studies – www.ear-cell.com ;
BladderCell
Read More
bladder regeneration = find a research partner + complete animal studies – bladdercell.com
BioLeonhardt Whole Body Regeneration
Read More
whole body regeneration and Bod-Stim bioelectric yoga and athletic pants = secure SBIR grant add CIP claims to patent + build and test body suit prototypes – https://leonhardtventures.com/bioleonhardt-whole-body/
InStim
Read More
bioelectric real time inflammation management = develop prototype + complete animal studies – https://instimcell.com/
OrthoStim
Read More
bioelectric joint recovery treatment = conduct clinical registry study USA – www.ortho-stim.com ;
COSMETIC and PERSONAL CARE (7)
Stem Cell Bra
Read More
breast regeneration = finish 2nd round of large animal studies. Launch first-in-man studies > find strategic partner – www.stemcellbra.com ;
DentaCell Accelerator
Read More
dental gum regeneration + tooth pulp storage = launch tooth pulp storage business, develop new dental innovations & startup – www.dentacellaccelerator.com ;
OrthodontiCell
Read More
bioelectric stimulator for accelerated tooth movement and freezing teeth positions straight = complete animal studies, complete first-in-man studies > find strategic partner – www.orthodonticell.com
SkinStim
Read More
skin regeneration = launch OUS first-in-man studies – www.skin-stim.com ;
MyoStim ED
Read More
bioelectric erectile dysfunction treatment = complete animal studies + launch OUS first-in-man studies – https://erectistim.com/
HairCell
Read More
hair regeneration = launch OUS first-in-man studies > find a strategic partner – www.haircellstim.com
Testistim
Read More
Bioelectric treatment of Low Testosterone – Testistim.com
ImplantStim
Read More
bioelectric and biologics innovations in dentistry – ImplantStim.com
Disclaimer Regarding the Term “Companies” Used in our Materials: In our accelerator and incubator terminology “companies” often refers to a new innovation being developed with full intention to form a separate spin out company IN-THE-FUTURE when the innovation has completed mentored incubated development into a full fledged organization with a web site, slide deck, basic business plan, board, team and has gotten some marketplace traction, including independent funding or revenues, to commence operations as a stand alone independent separately legally formed corporation. We DO NOT file “companies” to become independent separate legal entity “C or S corporations” until they are at an advanced stage of development and are deemed by our board or lead management to be ready to survive on their own. All early stage seed “companies” within the accelerator/incubator share the same accelerator or venture fund checking account, accounts payable and receivable clerks, accountants, lawyers, web site developers, support staff, consultants, advisory board, conference rooms, offices, telephone systems, internet wifi accounts and even management personnel until they are advanced enough with a dedicated focused team in place with strength enough to be pushed out of the next to fly on their own and feed themselves (get their own independent funding). We avoid filing to early stage “companies” to be independent stand alone legally registered ” C or S corporations” until they are truly deemed to be fully ready to be self reliant. This avoids un-necessary legal fees associated with city, county, state and federal filings. So until they are legally spun out as a separate entity these “companies” or “innovations” are officially product innovation development teams or projects under the Cal-X Stars Business Accelerator, Inc. or Leonhardt Vineyards LLC DBA Leonhardt Ventures umbrella organizations. Our Private Placement Memorandum for Cal-X Stars Business Accelerator, Inc. published on the password protected sitewww.healthiosxchange.com (reserved for verified accredited investors only) provides clear guidance on which “companies” have moved from being internal or external innovations under development into full fledged separate stand alone legal entities.
Accuracy of Information Disclaimer: Representations and warranties – although we fully believe that our executive summaries, newsletters, websites and other written materials and videos accurately represent a true and accurate general high level picture of our activities, history and progress – which is developing about 15 early stage un-proven cardiovascular life innovations and 15 early stage startup social good impact innovations (including new media social good projects) in an accelerator/incubator – we acknowledge that working with a very small core staff covering many thousands of pages of written materials across over 40 web sites with over 4000 sub-pages that we are highly prone to small errors, outdated materials and a certain level on inaccuracy and inconsistencies even while fully striving for the utmost accuracy. Across the 30 innovations and over 2000 working partnerships being developed there are changes and events that occur almost daily. We do our best to keep all websites and published materials fully up to date but recognize and make clear it is nearly impossible for our small staff to keep all materials on all web sites 100% up to date despite our best efforts to do so. Investors have the advantage with us that our small staff operates with a very low overhead but the offset disadvantage is that we do not have on hand the staffing to handle all the constant updates and proofreads needed to keep thousands of pages of materials up to date and 100% accurate 100% of the time. If you have ANY direct question about any published item of material interest to you – JUST ASK for clarification by emailing direct Howard Leonhardt at hleonhardt@aol.com or calling our office DIRECT LINE at 310 310 2534. We will strive to provide a clarification or update to you promptly.